HQL Operating Income Growth
abrdn Life Sciences Investors Shares of Beneficial Interest · Operating Income Growth
HQL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported346.97%period ending
HQL TTM Operating Income YoY % (-9.33% → 346.97%)
Year-over-year change
High-resolution chart · PNG
HQL operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 346.9668% | |
| 684.7723% | |
| -46.5642% | |
| 87.7696% | |
| 43.0262% | |
| -191.9084% | |
| -189.4861% | |
| -121.3651% | |
| -47.0967% | |
| 56.0848% | |
| 501.55% | |
| 1,952.9505% | |
| 592.8261% | |
| -79.6225% | |
| -189.5178% | |
| -46,982.9331% | |
| -22,479.1954% | |
| 9.908% | |
| 9.552% | |
| -0.293% | |
| -12.271% | |
| -37.5395% | |
| 98.0376% | |
| 99.52% | |
| 87.5331% | |
| 74.7056% | |
| 43.8479% | |
| 11.7463% | |
| -4.3354% | |
| -12.7202% | |
| 2.7728% | |
| 15.8155% | |
| -4.486% | |
| -31.1015% | |
| -39.3229% | |
| -51.8033% | |
| -10.0287% | |
| 22.3919% | |
| 27.2158% | |
| 30.5654% | |
| 13.3695% | |
| -4.6211% | |
| -7.7897% | |
| -11.3169% | |
| -10.1931% | |
| -8.9686% | |
| -14.3558% | |
| -20.8672% | |
| -16.9297% | |
| -9.3333% |